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of gluten-free products. Patients can buy 
 gluten-free foods using these coupons in 
any territorial pharmacy.
Given the significant social impact of 
celiac disease and the increasing number 
of cases, we conducted a survey with the 
aim (i) to show the updated prevalence of 
the disease in a defined population and (ii) 
to evaluate the economic impact.
Methods
We studied the population of the South 
Vesuvian area of Naples (Italy). It com-
prises eight Sanitary Districts and a 
total resident population of 558.939 as 
reported on January 2012 according to 
ISTAT (Istituto nazionale di STATistica, 
National Institute of Statistics); 271.039 
were males (M) and 287.900 females (F). 
Each pharmaceutical service has a database 
(Report Data Celiac disease – RDC) in an 
electronic format which converges through 
a central coordination service into a sin-
gle regional database. The RDC stratifies 
the population in groups by age (0–1, 2–4, 
5–10, 11–18, 19–65, >65 years), and gender 
(M vs. F). The number of celiac patients 
and the related expenditure of the LSA 
(ASL NA 3 South) are reported for each 
class. The final database is then transmit-
ted to the Pharmaceutical Sector of the 
Campania Region (Italy). The value in 
euro of each coupon is calculated accord-
ing to a table of the Ministerial Decree 
(May 4, 2006): for the age group between 
6 months and 1 year the value of each cou-
pon is € 45 (M = F); 1–3.5 years, the value 
is € 62 (M = F); >3.5–10 years, the value is 
€ 94 (M = F); for 10 years or older, the value 
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IntroductIon
Celiac disease is a chronic digestive  disorder 
of genetic origin in which damage to the 
lining of the small intestine, caused by 
an immunological reaction to gluten, 
leads to the malabsorption of minerals 
and nutrients (1). Signs and symptoms of 
celiac disease may vary among individuals 
depending on the degree of malabsorp-
tion: they range from absent, few or mild, 
to many or severe. There is no specific cure 
for celiac disease; the main treatment is a 
gluten-free diet (2).
The social impact of celiac disease is 
very high and its estimated prevalence in 
Italy is about 1.5%. The Italian law no.123 
(July 4, 2005) recognizes the celiac dis-
ease as “social disease” and ensures the 
free distribution of gluten-free aliments. 
However, there is no national legisla-
tion regulating the delivery modalities of 
gluten-free foods for patients with celiac 
disease; there are only some regional laws 
or even internal corporate regulations that 
establish the paths of delivery of gluten-
free foods.
In the Local Sanitary Agency (LSA) 
Naples 3 South Italy (i.e., LSA, NA 3 South), 
patients with celiac disease are taken into 
care by the Units of Basic Medicine of their 
Health District (a subunit of the LSA); sub-
sequently, the pharmaceutical service emits 
a booklet composed of 12 coupons cor-
responding to the 12 months of the year. 
The value in euro of each coupon varies 
according to age and gender of the patient 
as reported in a table of a specific Ministerial 
Decree (May 4, 2006); it determines exactly 
the expenditure cut-off for the delivery 
of each coupon corresponds to € 140 for 
males and € 99 for females. Additionally, 
in the District of Herculaneum, considered 
as “pilot district,” a short interview with 
a pre-printed form was administered to 
patients with celiac disease (to parents in 
patients younger than 18 years) in order 
to assess the degree of satisfaction of their 
food needs.
results
In the observed population (see 
Methods), we found 1453 celiac sub-
jects, 497 were male (M) and 956 female 
(F). The prevalence of celiac disease was 
2.6/1000, with a prevalence of 1.8/1000 
in male and 3.3/1000 in female. The male 
to female ratios (M/F) in specific age 
classes were: in the range of 0–1 years, 
32.0% M and 68.0% F (0.47); in the range 
2–4 years, 33.3% M and 66.7% F (0.49); 
in the range of 5–10 years, 37.1% M and 
62.9% F (0.58); in the range 11–18 years, 
36.0% M and 64.0% F (0.56); in the range 
of 19–65 years, 28.8% M and 71.2% F 
(0.40); in patients >65 years, 37.5% M 
and 62.5% F (0.6). The costs were calcu-
lated according to the above mentioned 
criteria (see Methods); they amounted 
to € 1620 for patients in the first class 
of age (6 months–1 year), € 33.480 for 
patients in the second class (1–3.5 years), 
€ 315.840 for patients in the third class 
(>3.5–10 years), and € 1.524.444 for 
patients in the fourth class (>10 year). 
The costs according to  gender were: 
€ 641.760 for male and € 882.684 for 
female. The total health expenditure was 
€ 1.875.384.
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to gluten. However, about 50% of cases are 
diagnosed in the adult stage (3). In the com-
ing years, we expect an increasing number 
of celiac patients over the age of 65 years, 
with strong implications in health care and 
economy.
According to the guidelines of the 
National Institute for Clinical Excellence 
in the UK (4), undiagnosed celiac disease 
is associated with a high number of long-
term complications, including osteoporosis 
and some malignant tumors. This suggests 
that significant savings may originate from 
changes in diet, with the use of gluten-
free products. In fact, the high economic 
impact of celiac disease cannot be ignored. 
Our survey conducted in a population of 
558.939 inhabitants of a single LSA of an 
Italian region shows a high health expendi-
ture (€ 1.875.384); these costs will augment 
with the increasing prevalence of the dis-
ease. Data emerging from our interviews 
suggest that resources allocated monthly 
to patients are quite adequate. However, 
prevention of the disease is the best tar-
get, not only for the obvious benefits for 
patients, but also for a strong reduction of 
sanitary costs.
In the district of Herculaneum, con-
sidered as a “pilot district,” 166 patients 
were interviewed (namely, 11.4% of total 
patients); 58 were M and 108 F. The inter-
views were anonymous and consisted on 
three brief questions: “How old are you?,” 
“What is your gender?,” and “Is the value 
of the coupon enough for you?” The com-
pliance to the questionnaire was very high. 
We found that 52.0% of patients believes 
that the budget is sufficient, 45.0% insuf-
ficient and only 3.0% did not respond to 
the questionnaire.
dIscussIon
Celiac disease is a medical condition with 
high social impact. The disease is cur-
rently underestimated; however, a sig-
nificant increase of affected patients has 
been observed over the last years with the 
improvement of diagnostic tools (i.e., labo-
ratory techniques) particularly in the age 
range of 0–1 year (3). In the other age classes 
it is registered an exponential increase of 
cases. For all classes of age, the M/F ratio 
is about 1/2, with a higher prevalence in 
women. Adolescence is a critical phase of 
risk for the development of the intolerance 
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